Abstract
The feasibility of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) and its comparability with bypass surgery in the treatment of unprotected left main coronary artery (LMCA) stenosis has been shown previously. We compared the mid- to long-term outcome between sirolimus-(SES) versus paclitaxel-eluting stents (PES) in an all-comer analysis that included all patients with unprotected LMCA stenosis who underwent PCI with SES or PES.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
